| dc.creator |
Kierstead, Elexis C. |
|
| dc.creator |
Harvey, Emily |
|
| dc.creator |
Sanchez, Denisse |
|
| dc.creator |
Horn, Kimberly A. |
|
| dc.creator |
Abroms, Lorien C. |
|
| dc.creator |
Spielberg, Freya |
|
| dc.creator |
Stanton, Cassandra A. |
|
| dc.creator |
Debnam, Charles |
|
| dc.creator |
Cohn, Amy M. |
|
| dc.creator |
Gray, Tiffany |
|
| dc.creator |
Magnus, Manya |
|
| dc.creator |
Patel, Minal |
|
| dc.creator |
Niaura, Raymond |
|
| dc.creator |
Elf, Jessica L. |
|
| dc.date |
2021-01-11T12:40:55Z |
|
| dc.date |
2021-01-11T12:40:55Z |
|
| dc.date |
2021-01-06 |
|
| dc.date |
2021-01-10T04:14:06Z |
|
| dc.date.accessioned |
2023-03-01T18:52:07Z |
|
| dc.date.available |
2023-03-01T18:52:07Z |
|
| dc.identifier |
BMC Research Notes. 2021 Jan 06;14(1):2 |
|
| dc.identifier |
http://hdl.handle.net/10919/101824 |
|
| dc.identifier |
https://doi.org/10.1186/s13104-020-05417-3 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/281587 |
|
| dc.description |
Abstract
Objective
Morbidity and mortality from smoking-related diseases among people living with HIV (PLWH) in the U.S. surpasses that due to HIV itself. Conventional smoking cessation treatments have not demonstrated strong efficacy among PLWH. We conducted a pilot randomized controlled trial (RCT) to evaluate a tailored smoking cessation intervention based on the minority stress model. We compared standard of care counseling (SOC) to a tailored intervention (TI) including one face-to-face counseling session incorporating cognitive behavioral therapy to build resilience, and 30 days of 2-way text messaging.
Results
The primary outcome was smoking cessation. Secondary outcomes included cigarettes per day (CPD), exhaled carbon monoxide (CO), and cessation self-efficacy. A total of 25 participants were enrolled (TI:11, SOC:14), and 2 were lost to follow-up. There were no significant differences in quit rates between study groups. However, there was a significantly greater decrease in CPD in the TI versus SOC (13.5 vs. 0.0, p-value:0.036). Additionally, self-efficacy increased in both groups (TI p-value:0.012, SOC p-value:0.049) and CO decreased in both groups (TI p-value: < 0.001, SOC p-value:0.049). This intervention shows promise to support smoking cessation among PLWH. A larger study is needed to fully evaluate the efficacy of this approach.
Clinical trial: Trial Registration: Retrospectively registered (10/20/2020) NCT04594109. |
|
| dc.description |
Published version |
|
| dc.format |
application/pdf |
|
| dc.format |
application/pdf |
|
| dc.language |
en |
|
| dc.rights |
Creative Commons Attribution 4.0 International |
|
| dc.rights |
http://creativecommons.org/licenses/by/4.0/ |
|
| dc.rights |
The Author(s) |
|
| dc.title |
A pilot randomized controlled trial of a tailored smoking cessation program for people living with HIV in the Washington, D.C. metropolitan area |
|
| dc.title |
BMC Research Notes |
|
| dc.type |
Article - Refereed |
|
| dc.type |
Text |
|
| dc.type |
StillImage |
|